Recent Stories
American Biotech — The Future Can’t Be Won Without It.RSI is AI Building AI. What DC needs to know about it. Keeping the Human in Medicine: Two AI CoLab Researchers on What Machines Can’t ReplaceSomeone Is Hacking the Freezers. Pay Attention.Thinking of Running in 2028? Start HereWhat the Lame Duck Session Has to Do With the Ultimate 21st-Century Power Tool: Robots

The Wave

Senatein sessionHousein session
Tracing STAT+: Cassidy sets key vote on Overton, even as he remains undecided on nominee to lead FDA×Refreshed 1 min ago
All24 hours
× Show allIn focus

Senate passes bipartisan permitting bill 62-33, sends it to House

The Senate passed the Bipartisan American Affordability and Jobs Act (BAAJA, S. 5653) 62-33 on Nov. 19 after a 70-27 cloture vote, and it now goes to a House that must decide whether to act in the lame-duck session. Speaker Mike Johnson and the White House back passage, while Hakeem Jeffries's position is mixed and House Democrats are split over passing now, amending, or waiting for the next Congress. Tribal groups, environmental groups and progressive Democrats oppose the bill over the NHPA Title III changes, NEPA and Clean Water Act limits, and data center provisions. · 1h ago

Forces, money & more Energy

Activity · 30 days back, 14 ahead

Total
37
Peak/day
5Nov 9
7d
16±0
Next
—
Σ/day5
Hill2
Contracts0
News35

In the News

One card per story, every outlet that covered it
19
  1. 4d agoYahooWhite House pulls FDA nominee Heidi Overton after wavering support from Senate RepublicansSTAT's Readout Loud podcast episode covers the Trump administration withdrawing Heidi Overton's FDA commissioner nomination, the FDA's rejection of Summit Therapeutics and Akeso's lung cancer drug, and STAT's new index ranking China's largest drugmakers.
    4 articles · 2 outlets
    1. 4d agoSTATSTAT+: White House pulls nomination of Heidi Overton to lead FDA
    2. 4d agoYahooPickupWhite House pulls FDA nominee Heidi Overton after wavering support from Senate Republicans
    3. 3d agoSTATSTAT+: 7 burning questions about the FDA’s post-Overton future
    4. 2d agoSTATEarliestFDA’s search for a new leader, and China’s largest drugmakers
    Biotech66 linked

On the Hill

Congress, the White House and agencies
16

Ahead

Recent

Wednesday, Mar 18

Times ET

Contracts

Solicitations, SBIR topics, grants and awards
6

Analytics cookies help us see how the site is used. They only run if you accept. Privacy Policy